Skip to main content

Table 6 Plasma Triglyceride level: effectiveness of treatments

From: The use of LeptiCore® in reducing fat gain and managing weight loss in patients with metabolic syndrome

 

Triglyceride (mean mg/dl)

change (%)

 

Initial

8 Weeks

8 Weeks - Initial

Formula B (↑dose)

167.61 ± 10.84

140.04 ± 4.29b*

-16.45‡

Formula A (↓dose)

162.21 ± 12.95

150.71 ± 8.30a

-7.09†

Placebo

168.93 ± 14.04

167.90 ± 10.30

-0.61

  1. ap < 0.05; bp < 0.001; compared with Placebo
  2. *p < 0.05; **p < 0.001; compared with Formula A
  3. †p < 0.05; ‡p < 0.001 compared with Initial; intragroup analysis
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X